<DOC>
	<DOC>NCT01367535</DOC>
	<brief_summary>This study is a single-center, randomized, open-label, active and placebo-controlled, parallel-group, conducted in healthy male volunteers who have been shown to be extensive metabolizers of dextromethorphan.</brief_summary>
	<brief_title>Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan</brief_title>
	<detailed_description />
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1. Healthy males between the ages of 18 and 55 2. NonSmokers 3. Body weight range form 154220 lbs 4. No history of clinically significant metabolic disorders. 1. Any history of low CYP450 2D6 activity 2. History of alcohol abuse or recreational drugs 3. History of any clinically significant disease or condition affecting a major organ system 4. Donation or loss of blood, 60 days proceeding to screening visit.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>